🇦🇺Australia

Delayed RDTI Tax Incentive Claims

2 verified sources

Definition

Trial design and recruitment generate eligible R&D expenditure, but compliance delays in record-keeping hinder timely RDTI claims (43.5% refund for small firms).

Key Findings

  • Financial Impact: AUD 100,000 - 1M forgone refund per delayed claim; 6-12 month ATO processing drag.
  • Frequency: Annual BAS claims; per eligible trial.
  • Root Cause: Manual aggregation of decentralized trial costs without audit-ready trails.

Why This Matters

The Pitch: Biotech firms in Australia 🇦🇺 miss AUD 500k+ in RDTI per trial due to slow verification. Automation streamlines eligible cost tracking.

Affected Stakeholders

Finance Director, R&D Tax Specialist, Compliance Officer

Deep Analysis (Premium)

Financial Impact

Financial data and detailed analysis available with full access. Unlock to see exact figures, evidence sources, and actionable insights.

Unlock to reveal

Current Workarounds

Financial data and detailed analysis available with full access. Unlock to see exact figures, evidence sources, and actionable insights.

Unlock to reveal

Get Solutions for This Problem

Full report with actionable solutions

$99$39
  • Solutions for this specific pain
  • Solutions for all 15 industry pains
  • Where to find first clients
  • Pricing & launch costs
Get Solutions Report

Methodology & Sources

Data collected via OSINT from regulatory filings, industry audits, and verified case studies.

Evidence Sources:

Related Business Risks

TGA Non-Compliance Penalties

AUD 50,000 - 500,000 per violation (civil penalties up to 5,000 penalty units at AUD 313/unit); 20-40% trial budget overrun from delays.

TGA CTN/CTA Notification Costs

30-60 hours per trial (at AUD 250/hr specialist rate = AUD 7,500 - 15,000)

Biosafety Non-Compliance Fines

AUD 10,000 - 500,000 per breach (typical civil penalty range for regulatory contraventions)

HREC and SSA Approval Delays

20-40 hours per trial site (at AUD 200/hr = AUD 4,000 - 8,000 opportunity cost)

Embryo Research Licensing Overhead

15-30 hours per licence application (AUD 3,000 - 6,000 at AUD 200/hr)

Datenmanipulation und Verstoß gegen Aufbewahrungspflichten in Forschungsvorhaben

Quantified (logic-based): For a typical biotechnology clinical or translational research project with a total budget of AUD 5–20 million, suspension or major protocol non‑compliance can reasonably jeopardise 2–5% of funding and add 1–2% in remedial compliance costs (≈ AUD 100,000–700,000 per affected project) through lost milestone payments, remedial monitoring and legal/consulting costs.

Request Deep Analysis

🇦🇺 Be first to access this market's intelligence